Table 2 Baseline severity of psychological and immunosuppression-related symptoms and levels of health-related quality and treatment adherence

PHQ-9 score

9 (7–13)

10 (8–18)

GAD-7 score

4.5 (2–7)

8 (7–10)

K-10 score

19.5 (17–21)

20 (16–25)

Difficulty with keeping scheduled follow-up visits^d

5 (4–5)

4 (4–5)

Difficulty with following a regular exercise program^d

2.5 (1–4)

2 (1–3)

Difficulty with following a healthy and balanced diet^d

4 (2–4)

2 (2–3)

Difficulty with having tests done as scheduled^d

5 (5–5)

4 (4–5)

Difficulty with taking all medicines as prescribed^d

5 (5–5)

4 (4–5)

Difficulty with side effects of medicines^d

4.5 (2–5)

4 (3–4)

Immunosuppression treatment adherence^a

100 (100–100)

95 (90–98)

Number of immunosuppression-related symptoms experienced ‘almost always’ or ‘always’^b

6.5 (3–12)

7 (3–12)

Physical functioning^c

70 (25–95)

40 (15–55)

Role limitations due to physical health^c

50 (0–75)

25 (0–75)

Role limitations due to emotional problems^c

0 (0–100)

100 (0–100)

Energy/fatigue^c

27.5 (5–50)

30 (20–35)

Emotional well-being^c

70 (64–72)

60 (60–64)

Social functioning^c

50 (50–63)

50 (50–50)

Pain^c

36 (33–48)

50 (35–58)

General health^c

53 (50–55)

50 (40–50)